RB1 and Merkel cell skin cancer: A point mutation in MCV LT that prevents binding to HSC70 inhibits proliferation of MCC cells and reduces expression of E2F target genes, suggesting that MCV LT may inhibit RB through its interaction with HSC70 in a manner similar to SV40 LT [92].